Investor Overview


Maria Sainz

Director, Chair of the Compliance Committee

Ms. Sainz became a director of Orthofix in November 2012, after previously having served on the Board from June 2008 to September 2011. Currently, she is the President and CEO of AEGEA Medical, Inc., a privately-held women’s health company in the field of endometrial ablation. Previously, Ms. Sainz served as the President, Chief Executive Officer, and Director of CardioKinetix Inc., a heart failure related medical device company. Prior to this, she was the President and Chief Executive Officer of Concentric Medical, Inc. up to and during its acquisition by Stryker Corporation in October 2011. Upon this acquisition, Ms. Sainz served as General Manager of the Stryker Neurovascular business unit. From 2003 to 2006, she was the President of the Cardiac Surgery division of Guidant Corporation. After Boston Scientific acquired Guidant, Ms. Sainz led the integration process for both the Cardiac Surgery and European Cardiac Rhythm Management business of Guidant into Boston Scientific. Between 2001 and 2003, she was the Vice President of Global Marketing–Vascular Intervention of Guidant. Ms. Sainz earned a Bachelor and Masters of Arts from the Universidad Complutense de Madrid and a Master’s Degree in International Management from American Graduate School of International Management. She has served as a director of Halyard Health, Inc. since February 2015 and of Iridex Corporation since April 2018. Ms. Sainz previously served as a director of The Spectranetics Corporation from 2010 until its sale in August 2017, and of MRI Interventions, Inc. from January 2014 to May 2018.

Independent Director